Answers are grounded in this paper and cite their sources.
Two patients with hepatocellular carcinoma (HCC) were treated with transjugular intrahepatic portosystemic stent-shunt (TIPS) and followed for 22 and 58 months thereafter. HCC was well controlled by transcatheter arterial chemoembolization. Hepatic failure or metastasis, especially in the lung, was not observed in the long-term observation. TIPS seems to be useful even in patients with HCC, provided HCC is controlled.
No takes yet. Share an insight, caveat, or question.
Tazawa et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: